M. Lakkaraja

Management of Chronic Immune Thrombocytopenia and Presumed Autoimmune Hepatitis in a Child with IKAROS Haploinsufficiency

D. Groth, M. Lakkaraja, J. Ferreira, 2020, Journal of Clinical Immunology.

Thrombopoietic agents: there is still much to learn.

J. Bussel, M. Lakkaraja, 2014, Presse medicale.

Maternal sensitization occurs before delivery in severe cases of fetal alloimmune thrombocytopenia

R. Berkowitz, J. Bussel, M. Lakkaraja, 2019, American journal of hematology.

Suppression of in vitro megakaryopoiesis by maternal sera containing anti-HPA-1a antibodies.

J. Bussel, M. Lakkaraja, H. Feldman, 2015, Blood.

Antithymocyte globulin exposure in CD34+ T-cell–depleted allogeneic hematopoietic cell transplantation

M. Perales, S. Devlin, A. Kung, 2021, Blood advances.

Omission of fetal sampling in treatment of subsequent pregnancies in fetal-neonatal alloimmune thrombocytopenia.

R. Berkowitz, J. Bussel, M. Lakkaraja, 2016, American journal of obstetrics and gynecology.

Blood group A mothers are more likely to develop anemia during antenatal intravenous immunoglobulin treatment of fetal and neonatal alloimmune thrombocytopenia

R. Berkowitz, J. Bussel, M. Lakkaraja, 2016, Transfusion.

Caregiver's Health Locus of Control and Medication Adherence in Sickle Cell Disease.

M. Lakkaraja, K. Viswanathan, Neeraja Swaminathan, 2015, Journal of the National Medical Association.

Early intestinal microbial features are associated with CD4 T cell recovery after allogeneic hematopoietic transplant.

Nicholas R. Waters, Y. Taur, M. Perales, 2022, Blood.